Literature DB >> 3993349

Fluorescein angiography in the long-term follow-up of choroidal melanoma after conservative treatment.

A Tarkkanen, L Laatikainen.   

Abstract

Three patients showed a growing choroidal melanoma, of them 2 in the only eye. The tumours were treated with Ru106/Rh106 plaques and surrounded by argon or krypton photocoagulation. The patients were followed up for 34-36 months by regular fluorescein angiography. In areas in which the radiation effect was optimal most choroidal and retinal vessels disappeared within 3-6 months. Outside this area occlusion of the vasculature as well as progressing atrophy of the tumour and the overlying retinal pigment epithelium were seen to continue for more than 12 months after treatment. Disappearance of the leaking vessels of the tumour may be the most reliable fluorescein angiographic sign of tumour regression following conservative treatment.

Entities:  

Mesh:

Year:  1985        PMID: 3993349     DOI: 10.1111/j.1755-3768.1985.tb05219.x

Source DB:  PubMed          Journal:  Acta Ophthalmol (Copenh)        ISSN: 0001-639X


  4 in total

1.  Indocyanine green angiography and fluorescein angiography of malignant choroidal melanomas following proton beam irradiation.

Authors:  Lothar Krause; Nikolaos E Bechrakis; Stefan Heinrich; Klaus-Martin Kreusel; Michael H Foerster
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-12-17       Impact factor: 3.117

2.  Imaging the microcirculation of untreated and treated human choroidal melanomas.

Authors:  A J Mueller; D U Bartsch; U Schaller; W R Freeman; A Kampik
Journal:  Int Ophthalmol       Date:  2001       Impact factor: 2.031

3.  Effect of beta-irradiation by a 106 ruthenium plaque on the rabbit eye choroid.

Authors:  D F Schaling; P K Lommatzsch; J L van Delft; D de Wolff-Rouendaal; J A van Best; J A Oosterhuis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

4.  Indocyanine green angiography of choroidal tumors.

Authors:  G Sallet; W M Amoaku; B A Lafaut; P Brabant; J J De Laey
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-11       Impact factor: 3.117

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.